There are many studies that tend to prove that the correction of iron deficiency intravenously decreases symptoms and improves patients’ quality of life.
Michel Galinier presents the main results, explaining to us that only the fer carboxymaltose has an indication and can help to treat this deficiency, the most common comorbidity of heart failurefound in particular in 50% of chronic heart failureet 75% of patients in the acute phase of this disease.
Find all the details in this video not to be missed!
Continue to explore the topic
This content is brought to you with the institutional support of
This video aims to provide information on the current state of research; the data presented may not be validated by the Health Authorities.
The CSL Vifor laboratory was not involved in the selection and writing of the scientific content. The scientific content has been produced under the sole and entire responsibility of the authors and the publication director, who guarantee the objectivity of this publication.
